Ratings by Jefferies (Kelly Shi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/12/2024 | Instil Bio Inc | TIL | Downgrade | Hold (Buy) |
10.92 (10.71) |
-1.92% | Details | |
| 4/1/2024 | Cogent | COGT | New Coverage | Buy (N/A) |
6.52 (7.12) |
9.2% | Details | |
| 3/20/2024 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2024 | ADC Therapeutics | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Incyte | INCY | New Coverage | Buy (N/A) |
60.33 (51.92) |
-13.94% | Details | |
| 2/20/2024 | ArriVent BioPharma | AVBP | New Coverage | Buy (N/A) |
22.07 (15.90) |
-27.96% | Details | |
| 2/12/2024 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2024 | Cabaletta Bio Inc. | CABA | New Coverage | Buy (N/A) |
20.58 (13.32) |
-35.28% | Details | |
| 1/11/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2024 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2023 | Ascendis Pharma | ASND | New Coverage | Buy (N/A) |
120.89 (142.10) |
17.54% | Details | |
| 11/30/2023 | Immunogen Inc. | IMGN | Downgrade | Hold (Buy) |
16.06 (31.25) |
94.58% | Details | |
| 11/15/2023 | Centessa Pharmaceuticals | CNTA | Upgrade | Buy (Hold) |
6.24 (10.00) |
60.26% | Details | |
| 11/7/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2023 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2023 | BeiGene, Ltd. | BGNE | New Coverage | Buy (N/A) |
202.72 (130.94) |
-35.41% | Details | |
| 8/11/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2023 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2023 | Immunitybio Inc | IBRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2023 | TCR2 Therapeutics | TCRR | Downgrade | Hold (Buy) |
1.60 (1.48) |
-7.5% | Details | |
| 12/21/2022 | ProKidney Corp | PROK | New Coverage | Buy (N/A) |
8.27 (2.72) |
-67.11% | Details | |
| 12/15/2022 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2022 | Instil Bio Inc | TIL | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Moonlake Immunotherapeutics | MLTX | New Coverage | Buy (N/A) |
8.50 (41.02) |
382.59% | Details | |
| 9/12/2022 | PTC Therapeutics | PTCT | New Coverage | Buy (N/A) |
53.64 (25.97) |
-51.58% | Details | |
| 9/1/2022 | CTI BioPharma | CTIC | New Coverage | Buy (N/A) |
6.11 (9.09) |
48.77% | Details | |
| 8/15/2022 | Monte Rosa Therapeutics | GLUE | New Coverage | Buy (N/A) |
9.16 (5.50) |
-39.96% | Details | |
| 8/15/2022 | Kymera Therapeutics | KYMR | New Coverage | Buy (N/A) |
32.51 (34.35) |
5.66% | Details | |
| 8/3/2022 | Immunitybio Inc | IBRX | New Coverage | Buy (N/A) |
3.65 (4.94) |
35.34% | Details | |
| 3/4/2022 | Adicet Bio Inc. | ACET | New Coverage | Buy (N/A) |
12.58 (2.00) |
-84.1% | Details | |
| 1/18/2022 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2022 | BioAtla Inc. | BCAB | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2021 | Immunogen Inc. | IMGN | Upgrade | Buy (Hold) |
4.75 (31.25) |
557.89% | Details | |
| 10/19/2021 | Legand Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2021 | Humanigen | HGEN | Downgrade | Hold (Buy) |
7.97 (0.04) |
-99.5% | Details | |
| 8/3/2021 | Hutchmed (China) Ltd. | HCM | New Coverage | Buy (N/A) |
42.79 (16.94) |
-60.41% | Details | |
| 6/14/2021 | AUTL | AUTL | Upgrade | Buy (Neutral) |
6.85 (4.56) |
-33.43% | Details | |
| 4/13/2021 | Connect Biopharma Holdings Ltd | CNTB | New Coverage | Buy (N/A) |
17.00 (1.35) |
-92.06% | Details | |
| 3/8/2021 | Adagene Inc | ADAG | New Coverage | Buy (N/A) |
22.99 (2.73) |
-88.13% | Details | |
| 10/30/2020 | Aldeyra Therapeutics | ALDX | New Coverage | Buy (N/A) |
6.42 (3.93) |
-38.79% | Details | |
| 2/11/2020 | I-Mab | IMAB | New Coverage | Buy (N/A) |
11.00 (1.80) |
-83.64% | Details |
